This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-closes-landmark-intra-cellular-therapies-acquisition-to-solidify-neuroscience-leadership
Reason: Acquired by Johnson & Johnson
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-closes-landmark-intra-cellular-therapies-acquisition-to-solidify-neuroscience-leadership
Intra-Cellular Therapies
ITCI
S$170.11
Share price
0.00%
Change (1 day)
93.50%
Change (1 year)
Categories
We have found no dividend yield history for this company